Molecular culprit behind virus-mediated chronic inflammation and cancers identified

April 26, 2018, Public Library of Science
BC-3 cells were stained with DAPI, anti-vFLIP, anti-CADM1, and cholera toxin B conjugated with red fluorescence to detect GM-1 and subjected to confocal microscopy. Credit: Hunte R et al. (2018)

Within cells infected by Kaposi sarcoma herpesvirus (KSHV), the human protein CADM1 interacts with viral proteins to promote chronic inflammation, which plays a major role in the development of cancers caused by KSHV. Richard Hunte of the University of Miami, Florida, and colleagues present these new findings in PLOS Pathogens.

About 12 percent of all cancers are linked to viruses such as KSHV, which causes Kaposi's sarcoma, , and the lymphoma-like multicentric Castleman's disease. These cancers are associated with caused by abnormal activation of the NF-κB in KSHV-infected cells. However, the molecular mechanisms of NF-κB activation are poorly understood.

Hunte and colleagues had previously found that the human CADM1 might play a key role in NF-κB activation caused by a different cancer-associated virus known as HTLV-1. In the new study, they investigated whether CADM1 plays a similar role in KSHV-infected cells.

The research team infected primary human cells with KSHV and found that CADM1 levels in the cells increased significantly within hours of infection. Moreover, they identified CADM1 protein level is significantly high in KSHV-caused cancer cells. Then, they used artificial RNA molecules known as short hairpin RNA to suppress CADM1 production in KSHV-infected cells. This revealed that CADM1 is necessary for NF-κB activation in these cells.

Next, the researchers examined whether CADM1 interacts with the proteins vGPCR and vFLIP, which are encoded in the KSHV genome and have been linked to NF-κB activation in previous research. They found that CADM1 is indeed required for vGPCR and vFLIP-mediated NF-κB activation and showed that a particular stretch at one end of the CADM1 protein is essential for this process.

Further experiments showed that CADM1 production is required for KSHV-infected cells to survive. Taken together, these findings suggest that CADM1 plays a key role in the survival and growth of cancer associated with KSHV infection.

This is especially notable because CADM1 is known to play the opposite role in other cancers, suppressing the growth of melanoma, lung , and other solid tumors. According to the authors, "targeting human protein CADM1 in viral-mediated cancers would be ultimate therapy against KSHV and HTLV-I associated malignancies."

Explore further: Male hormones may promote infection by virus that causes Kaposi's sarcoma

More information: Hunte R, Alonso P, Thomas R, Bazile CA, Ramos JC, van der Weyden L, et al. (2018) CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation. PLoS Pathog 14(4): e1006968. doi.org/10.1371/journal.ppat.1006968

Related Stories

Male hormones may promote infection by virus that causes Kaposi's sarcoma

September 28, 2017
Male hormones may facilitate infection with a virus that can cause a type of cancer known as Kaposi's sarcoma. This finding, published in PLOS Pathogens by Ke Lan's group of the State Key Laboratory of Virology, Wuhan University, ...

Viral microRNAs responsible for causing AIDS-related cancer

January 13, 2014
For the first time, scientists and engineers have identified a critical cancer-causing component in the virus that causes Kaposi's sarcoma, the most common cancer among HIV-infected people. The discovery lays the foundation ...

Stress wakes up sleeping herpes viruses – but how?

February 24, 2016
Hiding their DNA genome inside the nuclei of the infected cells, the herpes viruses establish a lifelong infection in humans. Poorly defined stress conditions are known to wake up these parasites from their latent phase and ...

Study identifies trigger for alternate reproduction of HIV-related cancer virus

April 17, 2012
A research team led by Children's National Medical Center has identified a trigger that causes latent Kaposi's sarcoma-associated herpesvirus (KSHV) to rapidly replicate itself. KSHV causes Kaposi's sarcoma, primary effusion ...

FSU scientist leads research on AIDS-related cancer

June 3, 2011
In the early days of the AIDS epidemic, a once-rare form of cancer known as Kaposi's sarcoma (KS) emerged as a frequent harbinger of HIV. Its stigma was best illustrated by Tom Hanks, who portrayed a gay man trying to conceal ...

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.